Symptom Management Guidelines: CONSTIPATION
Appendix A: Pharmacological Agents that may be used to Manage Constipation below The information contained in these documents is a statement of consensus of BC Cancer professionals regarding their views of currently accepted approaches to treatment.
Download Symptom Management Guidelines: CONSTIPATION
Information
Domain:
Source:
Link to this page:
Documents from same domain
Oncology Nutrition High Protein High Energy …
www.bccancer.bc.caHigh Protein High Energy Food Choices 3 Examples of High Protein Foods • All meat (eg. beef, pork, goat, lamb) • Fish and shellfish • All poultry (eg. chicken, turkey, duck)
BC CANCER HAZARDOUS DRUG LIST
www.bccancer.bc.caBC CANCER HAZARDOUS DRUG LIST (Refer to: Pharmacy Directive VI-80 Hazardous Drug List) The BC Cancer Hazardous Drug List (BC Cancer HD List) is comprised of:
Safe Handling of Hazardous Drugs - BC Cancer
www.bccancer.bc.caA.1 Potential Hazards of Handling Hazardous Drugs..... 1 A.2 Hazardous Drug List.....
“Magic” mouthwash explained - BC Cancer
www.bccancer.bc.caFAMILY PRACTICE ONCOLOGY NETWORK JOURNAL / FALL 2014 3 “Magic” mouthwash explained By Dr. Allan Hovan, Provincial Professional Practice Leader,
Symptom Management Guidelines: ORAL …
www.bccancer.bc.caSymptom Management Guidelines: ORAL MUCOSITIS . Definition Oral Mucositis (Stomatitis): An acute inflammation and/or ulceration of the …
Guidelines for Management of CID - BC Cancer
www.bccancer.bc.caDisclaimer Both the format and content of the guidelines will change as they are reviewed and revised on a periodic basis. Any physician using these guidelines to provide
British Columbia Cancer Agency POLICY
www.bccancer.bc.caBritish Columbia Cancer Agency ¦ POLICY Title: PREVENTION AND MANAGEMENT OF EXTRAVASATION OF CHEMOTHERAPY Number: III-20 Effective Date: Provincial Systemic Program September 1,1997
Symptom Management Guidelines: FEVER AND …
www.bccancer.bc.caSymptom Management Guidelines: FEVER AND NEUTROPENIA . Definition • Fever: A single oral temperature of ≥ 38.3° C (101° F) OR a temperature ≥ 38 ° C (100.4 ° F) which lasts more than 1h
Symptom Management Guidelines: XEROSTOMIA
www.bccancer.bc.caSymptom Management Guidelines: XEROSTOMIA. Definition(s) • Xerostomia: abnormal dryness in the mouth characterized by a marked decrease and/or thickening of saliva, may be
Linking the BC Psychosocial Community Oncology …
www.bccancer.bc.caCarolyn Jacob - New Regional Professional Practice Leader at the Centre for the North. We welcome Carolyn Jacob, MSW, RSW to her new role at the BC
Related documents
Pharmacologic Treatment of Insomnia - Sleep
aasm.orgthe pharmacological treatment of insomnia have previously been issued by the AASM, despite the fact that this remains, by far, the most common approach to therapy, after treatment of comorbidities. Pharmacotherapy is one of two major ap-proaches to treatment, the alternative being cognitive behav-
Guideline for the pharmacological treatment of ...
apps.who.int3.1 Blood pressure threshold for initiation of pharmacological treatment 7 3.2 Laboratory testing before and during pharmacological treatment 8 3.3 Cardiovascular disease risk assessment as guide to initiation of antihypertensive medications 10 3.4 Drug classes to be used as first-line agents 11 3.5 Combination therapy 13
STATUS EPILEPTICUS (SE) TREATMENT ALGORITHM IN ADULTS
nypem.netexpert opinions at NYPH. There is a lack of consensus among neurocritical care clinicians and epileptologists on the pharmacological approach to treatment of generalized conv ulsive status epilepticus after failure of a benzodiazepine. The suggestions …
Centers for Medicare & Medicaid Services 7500 Security ...
www.medicaid.govOct 22, 2021 · treatment and care, or otherwise incorporate the judgment of health care professionals, to determine whether a non-pharmacological item or service must be covered under the ARP amendments, and can opt to establish other utilization management controls, consistent with 42
DEFINITION OF ACTIVE PHARMACEUTICAL INGREDIENT
www.who.intpharmacological activity or to otherwise have direct effect in the diagnosis, cure, mitigation, treatment or prevention of disease, or to have direct effect in restoring, correcting or modifying physiological functions in human beings." If this is agreed to, it should be applicable to future WHO documentation or any current
Standard Treatment Guidelines - WHO
www.who.intTable 19-11:Pharmacological Treatment of Worm Infestations Table 20-1: Dose of Vitamin A for Xerophthalmia Table 20-2: Characterising Acute Red Eye with no history of Injury Table 20-3: Summary of the Common Causes and Management of Conjunctivitis